Myovant Sciences
achieved significant response rates for non menstrual pelvic pain in spirit and rates | Myovant Sciences
Company
Deck Type
Sector
Industry
Deck date
August 2022
Slide
13 of 34
Similar slides by Myovant Sciences
See diffirences between slides (animation)
Results
August 2022
majority of women treated with who used at were free at week | Myovant Sciences
Results
August 2022
reduced the impact of pain on activities as shown by pain domain domain phi | Myovant Sciences
Results
August 2022
achieved sustained reductions in non menstrual pelvic pain scores scores | Myovant Sciences
Results
August 2022
achieved sustained reductions in dysmenorrhea scores scores | Myovant Sciences
Related slides by other companies
Asos
Investor Day
November 2021
this has been achieved through driving significant efficiencies in our cost base i | Asos
Morgan Stanley
Investor Conference
January 2022
significant growth opportunity in workplace build new relationships grow unvested assets retain vested assets stock plan vested asset retention rate | Morgan Stanley
Embracer Group
Results
May 2023
result of the employee survey | Embracer Group
Nuwellis
Investor Presentation
March 2023
diuretics significant limitations as current standard of care high risk of long term use of diuretics is associated with kidney damage diuretics provide insufficient symptom relief and are associated with worsening heart failure and increased mortality after discharge of heart failure patients have poor diuretic response damage discharge response | Nuwellis
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io